RGLS
Regulus Therapeutics Inc.
10% owner Paul Edward Walker bought $1.2M of Regulus Therapeutics Inc.
Bought$1,227,640
$1.08Price
1,136,704Shares
+124%Stake
What RGLS did for a copier
Prices for RGLS after this filing aren't in yet.
Paul Edward Walker's record
6 other buys with 3 months of prices since 2019: on average −6.6% against the S&P 500, and 2 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, May 7. Filed Fri, May 10, 6:59 AM ET, before the open. Not investment advice.